NCPDP

NCPDP Announces Emmy-Winning David Pogue to Deliver Keynote Address for Its 2024 Annual Conference "Innovation Starts Here"

Retrieved on: 
Tuesday, February 20, 2024

SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here". The Annual Conference, which will be held May 6-8, 2024, at the Westin Kierland Resort & Spa in Scottsdale, Arizona, is expected to draw more than 700 attendees representing a broad cross-section of pharmacy and other healthcare-related industry segments.

Key Points: 
  • SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here" .
  • "Mr. Pogue will bring a diverse, interdisciplinary perspective that will motivate NCPDP's Annual Conference attendees to think differently about the future of healthcare technology."
  • NCPDP's 2024 Annual Technology & Business Conference "Innovation Starts Here" is open to all healthcare industry stakeholders.
  • For real-time updates before and during the event, follow @NCPDP on X, NCPDP on LinkedIn, or join the discussion using NCPDP's 2024 Annual Technology & Business Conference hashtag: #NCPDP24.

NCPDP Foundation Awards $150,000 Grant to RxLive to Automate Tracking of Physician Adoption of Pharmacists' Clinical Recommendations

Retrieved on: 
Wednesday, December 20, 2023

SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive, a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions. RxLive will use NCPDP standards along with RxLive's expansive network across both acute and ambulatory care settings, including its platform integration with the Surescripts network and Health Gorilla Health Information Exchange, to pilot a process that can be used for bidirectional communication of patient-specific clinical information that will allow pharmacists to consult with patients, share their clinical recommendations with physicians, and track adoption of pharmacists' recommendations - to better coordinate care and improve patient health outcomes.

Key Points: 
  • SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive , a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions.
  • "The NCPDP Foundation grant to RxLive has the potential to document at scale the measurable value pharmacists bring to patients and the patient care team," explained J.W.
  • The goal of the project is to quantify and analyze clinical interactions between pharmacists and patients and how often providers take action as a result of the pharmacist's clinical recommendations.
  • RxLive will introduce a natural language processing (NLP) interface to ease adoption of the Sig Format.

FDB Vela™ Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance

Retrieved on: 
Wednesday, December 6, 2023

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Vela™ ePrescribing network, one of FDB's newest solutions, has earned HITRUST Risk-based, 2-year (r2) Certified status demonstrating the highest level of information protection assurance.

Key Points: 
  • HITRUST Risk-based, 2-year (r2) Certified status demonstrates that FDB Vela has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk.
  • This achievement places FDB in an elite group of organizations worldwide that have earned this certification.
  • To achieve the HITRUST Risk-based, 2-year Certification, FDB Vela surpassed requirements across various comprehensive cybersecurity and data protection domains.
  • Individually, each element exceeds most other programs and collectively they make HITRUST Certification the most comprehensive, transparent, consistent and highest quality assessment available."

Xact Laboratories Announces Strategic Partnership with a national Switch to provide integrated PGx results at the point of prescription fulfillment

Retrieved on: 
Wednesday, November 29, 2023

Xact integrates PGx results at the Switch for real-time medication guidance for providers and pharmacists.

Key Points: 
  • Xact integrates PGx results at the Switch for real-time medication guidance for providers and pharmacists.
  • In addition, Xact's integration of PGx data at the Switch will drive improvements in health plan initiatives, formulary adherence, and beneficiary satisfaction.
  • Rob Todd, managing partner of Xact Laboratories, expressed his enthusiasm about the partnership, "We believe that every patient deserves personalized, evidence-based healthcare.
  • PGx testing is revolutionizing the healthcare industry by allowing providers to tailor prescription drug regimens to an individual's genetic makeup.

NCPDP Foundation Awards $79,000 Grant to Digital Therapeutics Alliance to Address Key Barrier for Patient Access to Clinically Validated Digital Therapeutic Products

Retrieved on: 
Wednesday, August 16, 2023

SCOTTSDALE, Ariz., Aug. 16, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $79,000 grant to Digital Therapeutics Alliance to research health plans' criteria for determining coverage pathways of DTx products and develop pharmacy and medical benefit workflows to illustrate how clinically validated digital therapeutic products can be integrated into benefit designs. The grant supports the NCPDP Foundation's strategic initiative to Expand Patient Access to Care in alignment with NCPDP's strategic goal to explore how standards can support a pharmacist's role in digital therapeutics. Findings from the research project will also include recommendations for enhancements to existing NCPDP standards or a new NCPDP standard to support DTx products.

Key Points: 
  • The grant supports the NCPDP Foundation's strategic initiative to Expand Patient Access to Care in alignment with NCPDP's strategic goal to explore how standards can support a pharmacist's role in digital therapeutics.
  • We are excited to fund this research which can help improve patient access to clinically validated digital therapeutics and advance interoperability of data that supports prescription digital therapeutics.
  • "We are excited to fund this research which can help improve patient access to clinically validated digital therapeutics and advance interoperability of data that supports prescription digital therapeutics," explained J.W.
  • Jessica Hauflaire, Chief Operating Officer, Digital Therapeutics Alliance said, "We thank the NCPDP Foundation for their remarkable support in breaking down this significant barrier to patient access.

NCPDP Opens the Call for Proposals for its 2024 Annual Technology & Business Conference, "Innovation Starts Here"

Retrieved on: 
Wednesday, August 2, 2023

SCOTTSDALE, Ariz., Aug. 2, 2023 /PRNewswire-PRWeb/ -- NCPDP announces the call for proposals for its NCPDP 2024 Annual Technology & Business Conference, "Innovation Starts Here," which will be held May 6-8, 2024, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. NCPDP's national conference draws more than 700 attendees from across the healthcare industry, including technical, business, and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

Key Points: 
  • NCPDP's national healthcare and pharmacy industry conference to take place May 6-8, 2024, in Scottsdale.
  • SCOTTSDALE, Ariz., Aug. 2, 2023 /PRNewswire-PRWeb/ -- NCPDP announces the call for proposals for its NCPDP 2024 Annual Technology & Business Conference, "Innovation Starts Here," which will be held May 6-8, 2024, at the Westin Kierland Resort & Spa in Scottsdale, Arizona.
  • NCPDP is accepting submissions for two session formats at its 2024 Annual Conference:
    Standard Track Sessions are 60-minute sessions, providing for a 45-minute presentation and 15 minutes of question and answer.
  • NCPDP encourages the submission of proposals covering a broad range of educational, informative healthcare and pharmacy topic areas, such as:

The Exceptional Women Alliance (EWA) announces selection of Melanie Marcus, Chief Marketing and Customer Experience Officer, Surescripts, as a 2023 Awardee

Retrieved on: 
Wednesday, August 2, 2023

LOS ANGELES, Aug. 2, 2023 /PRNewswire-PRWeb/ --The Exceptional Women Alliance (EWA) announces the selection of 2023 awardee Melanie Marcus, Chief Marketing and Customer Experience Officer for Surescripts. With over 30 years of experience working at the intersection of marketing, technology, and healthcare, her role of "chief storyteller," helps people understand how technology unites our fragmented healthcare system. She also currently hosts Surescripts' award-winning podcast, There's A Better Way: Smart Talk on Healthcare and Technology.

Key Points: 
  • The Exceptional Women Alliance (EWA) announces that after an expansive search and in-depth interview process, Melanie Marcus, Chief Marketing and Customer Experience Officer of Surescripts, was selected as a 2023 EWA.
  • LOS ANGELES, Aug. 2, 2023 /PRNewswire-PRWeb/ --The Exceptional Women Alliance (EWA) announces the selection of 2023 awardee Melanie Marcus, Chief Marketing and Customer Experience Officer for Surescripts.
  • Ms. Marcus has a robust background as a healthcare marketing, customer experience and strategic executive.
  • "We are thrilled to welcome Melanie with her rich background in marketing and passion for enabling people to excel.

NCPDP Foundation Announces its Call for Grant Proposals, Due July 31, 2023

Retrieved on: 
Tuesday, May 23, 2023

SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting patient safety, access to care and the expanded role of pharmacists. Grant proposals must meet the grant proposal requirements and be submitted electronically by July 31, 2023, to be considered for the current grant funding cycle.

Key Points: 
  • Grant proposals must meet the grant proposal requirements and be submitted electronically by July 31, 2023, to be considered for the current grant funding cycle.
  • Research projects must benefit at least one of the NCPDP Foundation strategic initiatives: increasing the role and value of pharmacists; increasing patient access to care; and enhancing patient safety.
  • In addition, research projects must seek to demonstrate and measure how an underutilized NCPDP Standard or a new use for an NCPDP Standard supports the strategic initiative and improves interoperability.
  • While these areas are currently of particular interest, the NCPDP Foundation welcomes and will evaluate other projects that meet the essential criteria.

NCPDP Announces its 2023 Champion Award Recipient at the NCPDP 2023 Annual Technology & Business Conference

Retrieved on: 
Wednesday, May 10, 2023

SCOTTSDALE, Ariz., May 10, 2023 /PRNewswire-PRWeb/ -- Today at its Annual Technology & Business Conference, NCPDP announced its 2023 Champion Award recipient, Admiral Brett Giroir, M.D., the 16th U.S. Assistant Secretary for Health, and Chief Executive Officer and member of the Board of Directors for Altesa Biosciences, Inc. NCPDP's Champion Award recognizes outstanding accomplishments or work to improve patient care by actively supporting NCPDP members and its initiatives.

Key Points: 
  • NCPDP President & CEO Lee Ann Stember stated, "This year, we are honored to present the Champion Award to Retired Admiral Brett Giroir, M.D.
  • We believe Dr. Giroir should be recognized for his long tenure in supporting access to care and enhancing interoperability as a Champion of NCPDP and our standards-setting process.
  • NCPDP's Annual Conference continues today with Keynote Speaker Robin Farmanfarmaian, speaker, author, and tech entrepreneur; and more educational programming and networking opportunities.
  • For real-time updates during the conference, follow https://twitter.com/NCPDP and join the discussion using the hashtag #NCPDP23.

FDB Vela™ Leader to Share Vision for Vastly Reducing Fill Times for Specialty Drug ePrescribing at NCPDP Annual Conference

Retrieved on: 
Thursday, May 4, 2023

SOUTH SAN FRANCISCO, Calif., May 4, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that Lathe Bigler, vice president of clinical network services for FDB Vela™, will share insights at the NCPDP 2023 Annual Technology & Business Conference on how prescribers can quickly and simply electronically prescribe specialty medications based on new standards, processes, and tools to reduce fill time from weeks to hours (in many cases) and give patients greater access to care.

Key Points: 
  • Recently celebrating its first anniversary, FDB Vela empowers innovation, reduces barriers to participation, and increases the cost-effectiveness of electronic prescribing.
  • These advances help close gaps in care in the specialty medication process while improving prescriber efficiency, increasing patient adherence, and reducing frustration for all involved.
  • Bigler continued, "The hurdles involved in the current state of specialty drug prescribing cause widespread dissatisfaction among stakeholders.
  • Also speaking at the NCPDP 2023 Annual Technology & Business Conference will be Chirag Patel, PharmD, MBA, senior product manager for FDB.